NGM Biopharmaceuticals Inc (NASDAQ:NGM)

13.78
Delayed Data
As of May 27
 +0.39 / +2.91%
Today’s Change
10.49
Today|||52-Week Range
27.25
-22.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2019

--

--

--
Revenue and IncomeNet Revenues25.6M------
 
 
Depreciation And Amortization2.0M------
 
 
 
Operating ExpensesGross Income----------
General Expenses32.9M------
 
 
Research And Development29.5M------
 
 
Total Operating Expenses34.9M------
 
 
 
Non-Operating ExpensesOperating Income-9.3M------
 
 
Other Expenses-36.0K------
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.3M------
 
 
Net Income-8.3M------
 
 
 
Shares To Calculate EPSShares To Calculate EPS66.0M------
 
 
Shares To Calculate EPS Diluted66.0M------
 
 
 
Earnings Per ShareEPS-$0.13------
 
 
EPS Diluted-$0.13------